Novavax, Inc. is a company in the U.S. stock market and it is a holding in 70 U.S.-traded ETFs. NVAX has around 6.7M shares in the U.S. ETF market. The largest ETF holder of NVAX is the SPDR S&P Biotech ETF (XBI), with approximately 1.79M shares. Investors may also find of interest that the ETF with the largest allocation to NVAX stock is ProShares Nanotechnology ETF (TINY), with a portfolio weight of 5.07%. On average, U.S. ETFs allocate 0.51% of NVAX to their portfolios.
Additionally, NVAX is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVAX as a holding is the Avantis U.S. Equity ETF (AVUS), with a return of --.